<DOC>
	<DOCNO>NCT00280644</DOCNO>
	<brief_summary>Study objective : - To provide insight modulation inflammation matrix degrade factor serum urine leflunomide early , active patient RA validate sensitivity DEMRI ( Dynamic Enhanced Magnetic Resonance Imaging ) detect inflammatory change active RA response treatment leflunomide - Effect leflunomide therapy physical function improvement Quality life</brief_summary>
	<brief_title>Leflunomide Rheumatoid Arthritis</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<mesh_term>Leflunomide</mesh_term>
	<criteria>Patient diagnosis rheumatoid arthritis base upon ACR ( American College Rheumatology ) diagnostic criterion Patient ARA functional class IV ( ACR 1991 revise criterion ) . Active disease define &gt; 6 swell tender joint , physician well patient global assessment disease activity moderate worse Patient active disease define modified Disease Activity Score ( DAS ) &gt; 3.2 At least one wrist joint active disease , define clinically detectable synovitis site due technical facility use wrist joint DEMRI ( Dynamic Enhanced Magnetic Resonance Imaging ) Patient receive unchanged dos oral corticosteroid ( maximum dose 10 mg prednisone daily steroid equivalent orally administer ) concomitant stable dos nonsteroidal antiinflammatory drug least 4 week enter study Woman childbearing potential , demonstrate pregnant ( serum pregnancy test ) breast feed screen visit , agree undergo urine pregnancy test monthly study , serum pregnancy test end treatment Woman childbearing potential , agree maintain adequate mean contraception get pregnant study 24 month discontinuation treatment.Man wish father child , consent discontinue treatment study medication , undergo drug elimination procedure The patient ARA functional class IV The patient history inflammatory joint disease , e.g . mixed connective tissue disease , seronegative spondylarthropathy , psoriatic arthritis , Reiter 's syndrome , systemic lupus erythematosus , sarcoidosis , history Felty 's syndrome , arthritis onset prior 16 year age The patient congenital acquire severe immunodeficiency , history cancer lymphoproliferative disease , he/she receive total lymphoid irradiation The patient know HIV positive status define either positive blood test clinical diagnosis The patient sick persistent infection severe infection within 3 month enrollment Known Glucose 6 Phosphate Dehydrogenase ( G6PD ) deficiency The patient acute intermittent porphyria The patient hematopoietic disorder ( haemoglobin &lt; 9 g/dl , White Blood Cells &lt; 3500/mm3 , platelet count &lt; 120.000/mm3 ) The patient impaired coagulation , treatment oral anticoagulants The patient uncontrolled diabetes , unstable ischaemic heart disease , active inflammatory bowel disease , active peptic ulcer disease history active peptic ulcer disease previous 4 month ( document gastroscopy clinically diagnosed physician ) , recent history major traumatic injury , history malignancy . The patient clinically relevant cardiovascular , hepatic , neurologic , endocrine , major systemic disease make implementation protocol interpretation study result difficult Patients body weight &lt; 45 kg The patient receive therapy within previous 3 month investigational drug , alkylating agent ( e.g . cyclophosphamide , chlorambucil ) , biological agent ( e.g . interferon , monoclonal antibody , growth factor , cytokine ) . The patient receive DMARD ( Disease Modifying Antirheumatic Drugs ) therapy ( Dpenicillamine , oral injectable gold , chloroquine , hydroxychloroquine , cyclosporine , MTX ) n't follow washout period 28 day Patients therapy oral corticosteroid exceed prednisone equivalent 10 mg/day , parenteral intraarticular corticoid injection , within previous 4 week The information intend contain consideration relevant patient 's potential participation clinical trial .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>January 2011</verification_date>
</DOC>